MDUFMA Branding Provision Reprieve To Be Explained In Upcoming Guidance
This article was originally published in The Gray Sheet
Executive Summary
FDA will give manufacturers 18 months to implement branding provisions of the Medical Device User Fee & Modernization Act upon issuance of a final guidance explaining how firms may achieve compliance
You may also be interested in...
MDUFMA Guidance Forecast: E-Labeling, Appeals, GMP Inspections
Legal concerns raised by FDA's Office of Chief Counsel likely will delay issuance of a planned Sec. 301 guidance, according to MDUFMA Implementation Director Joanne Less, PhD
MDUFMA Guidance Forecast: E-Labeling, Appeals, GMP Inspections
Legal concerns raised by FDA's Office of Chief Counsel likely will delay issuance of a planned Sec. 301 guidance, according to MDUFMA Implementation Director Joanne Less, PhD
Reprocessed SUD Recall Underlines Sec. 301 Branding Concerns – OEMs
A recent recall by reprocessor MedSurg Solutions could spur FDA to change its format for recall notices